1-855-378-42281-855-378-4228
One of the outpatient rehabilitation alternatives for people in Williamsville battling with opioid dependence and addiction is opioid maintenance therapy. Some facilities and doctors are certified to administer certain medications to opioid addicted individuals, many of which are opioid-based themselves and are habit forming. In low amounts however, the client does not experience high feelings but also doesn't experience intense cravings and isn't in opioid withdrawal. Methadone is the first med administered for this reason, but there are alternative choices to select from.
Methadone is an opioid and is meant to be taken at an out-patient clinic licensed to administer the med, that is taken daily in liquid or pill form. The price of the drug is about $150 per month. Buprenorphine is also an opioid based med, and is a pill often taken every other day. But unlike Methadone that is only be administered in structured medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The monthly cost of buprenorphine is approximately just under $300 monthly for the generic of the drug. There is also a version of buprenorphine that contains the ingredient naloxone, that is a med which blocks the effects of opiates. An individual taking this formulation, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It too is taken on a daily basis, and is priced about $450 monthly. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other medications aforementioned it is an opiate blocker and isn't an opiate. A person has the choice to take this medication as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents someone from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
For All Drug and Alcohol Rehabilitation Facilities In Williamsville, Click Here.
